Celcuity Inc. CELC
Set alert
At close · Nov 2
After hours · Nov 2, 4:37 PM ET
- YTD
- -32.76%
- 1 year
- -13.08%
- Open
- 69.50
- Prev close
- 69.13
- Mkt cap
- 3.28B
- Vol
- 775.82K
- Avg vol
- 1.18M
- EPS
- -4.31
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 66.20
- High
- 70.13
- Forward P/E
- -838.38
- Beta
- 0.13
- Short ratio
- 7.39
- Inst. own
- 112.68%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 77.67
- 200-d avg
- 100.63
- 1y target
- 154.72
5D chart
Signals (109)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:00 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:35 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:25 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:10 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:10 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:05 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:45 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:45 AM | 3 days ago |
Newest 20 of 109.
Discussion (41)
Sign in to join the discussion
Gal CELC 5 months ago #1investors.com/news/technologycelcuity-stock-three-drug-regimen-breast-cancer/?src=A00220
#CELC
The article says Celcuity's phase 3 breast-cancer regimen produced strong results: the triple combo of gedatolisib, palbociclib, and fulvestrant cut the risk of progression or death by 76%, and the doublet cut it by 67% versus fulvestrant
alone. clinicaltrialsarena +1
It also says median progression-free survival was 9.3 months for the triple therapy and 7.4 months for the doublet, compared with 2.0 months for the control arm, and that Celcuity planned an FDA filing in Q4 2025.
REDDIT MASTER CELC 5 years ago #2$CELC INTERNAL NEWS ** THIS STOCK WILL BE COLLAPSED SOON DUE TO FAIL OF THE PRODUCT IN PHASE II .
REDDIT MASTER CELC 5 years ago #3$CELC NO VOLUMES ！ DO BODY BUY ! HOLD IS LOSING POCKETS MONEY.
REDDIT MASTER CELC 5 years ago #4 REDDIT MASTER CELC 5 years ago #5$CELC FROM INTERNAL NEWS :THIS IS LOSING ALOT OF MONEY COMPANY.
THE RESEARCH BURNED MONEY AND GET NOTHING.
REDDIT MASTER CELC 5 years ago #6$CELC TIME TO SELL AND GET PROFIT NOW.
HOLDING WILL LOSING POCKETS MONEY.
REDDIT MASTER CELC 5 years ago #7$CELC NO VOLUMES... MEANS NO BODY WANT TO BUY.
LOSING MONEY COMPANY.
SELL IS STRONGLY RECOMMENDED...
REDDIT MASTER CELC 5 years ago #8 REDDIT MASTER CELC 5 years ago #9 REDDIT MASTER CELC 5 years ago #10